Fidson Healthcare Plc 2016 Financial Summary
Principal Activities
The principal activities of the Company are the manufacture and distribution of pharmaceutical products. The company commenced local manufacturing of pharmaceutical products in July 2002
Legal Form
The company operated as a Private Limited Liability Company until June 5, 2008 when it was registered as a Public Limited Liability Company. The shares are currently quoted on the Nigerian Stock Exchange.
Major Shareholders
Dr. Fidelis Ayebae 29.77%
Glorious Haven Ltd 5.74%
Stanbic Nominee 5.67%
CSP Nominee 12.91%
12 Months Report FIDSON HEALTHCARE PLC | ||||
2016 N'000 | 2015 N'000 | change | Year End | |
Revenue | 7,655,029 | 8,210,760 | -7% | December |
Profit/Loss before taxation | 443,787 | 838,039 | -47% | |
Profit/Loss for the period | 316,762 | 744,378 | -57% | |
Issued Shares (Units) | 1,500,000,000 | 1,500,000,000 | ||
Basic Earnings Per Shares (Kobo) | 21.00 | 50.00 | -58% | |
Last total dividend paid (Kobo) | 5.00 | 5.00 | 0% |
Quarter on Quarter performance
Revenue PAT
N'000 N'000
Q1: #1,217,378 Q1: #28,478
Q2: #1.393,318 Q2: #11,104
Q3: #1,916,308 Q3: #42,493
Q4: #3,128,025 Q4: #234,687
Fidson maintained an average of #1.9billion in terms of revenue in 2016 and #79.1million in terms of PAT. The Q4 performance was a master class in revenue and PAT. We expect the company to maintain the tempo in 2017. The Q1 2017 will actually say more about this.
A closer look at the result shows that Fidson needs to sell and manage its administrative and selling and distribution expenses to remain competitive. The healthcare sector had its own fair share of the economic down turn of 2016, the reason most of them did not do well. We hope 2017 would be fair enough.
The Company Declared a dividend of 5k same divided paid in 2105.
Comments
Post a Comment